MetLife RIS — Net investment income from equity method investments decreased by 30.0% to 7.0% in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 40.0%, from 5.0% to 7.0%. Over 2 years (FY 2021 to FY 2023), RIS — Net investment income from equity method investments shows a downward trend with a -80.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher income reflects strong performance of the underlying equity method investments.
Income generated from investments in entities where the segment has significant influence but not full control, accounte...
Commonly reported as 'Income from Equity Method Investments' or 'Alternative Investment Income' in insurance segment disclosures.
met_segment_ris_net_investment_income_from_equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 6.5% | 6.5% | 6.5% | 1.5% | 1.5% | 1.5% | 1.5% | 0.3% | 0.3% | 0.3% | 0.3% | 4% | 4% | 2% | 5% | 4% | 10% | 7% |
| QoQ Change | — | +0.0% | +0.0% | -76.9% | +0.0% | +0.0% | +0.0% | -83.3% | +0.0% | +0.0% | +0.0% | >999% | +0.0% | -50.0% | +150.0% | -20.0% | +150.0% | -30.0% |
| YoY Change | — | — | — | — | -76.9% | -76.9% | -76.9% | -83.3% | -83.3% | -83.3% | -83.3% | >999% | >999% | +700.0% | +25.0% | +0.0% | +400.0% | +40.0% |